(VIANEWS) – Agnico Eagle Mines Limited (AEM), Incyte Corporation (INCY), Mitek Systems (MITK) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Agnico Eagle Mines Limited (AEM)
18.4% sales growth and 13.14% return on equity
Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland. The company operates through Northern Business and Southern Business segments. It primarily produces and sells gold deposit, as well as explores for silver, zinc, and copper deposits. The company's flagship property is the LaRonde mine located in the Abitibi region of northwestern Quebec, Canada. As of December 31, 2019, its LaRonde mine had a mineral reserve of approximately 2.9 million ounces of gold. The company is also involved in exploration activities in Europe, Latin America, and the United States. Agnico Eagle Mines Limited was founded in 1953 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Agnico Eagle Mines Limited has a trailing twelve months EPS of $5.08.
PE Ratio
Agnico Eagle Mines Limited has a trailing twelve months price to earnings ratio of 9.66. Meaning, the purchaser of the share is investing $9.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.14%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 26.7% and positive 7.7% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 5.93B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Agnico Eagle Mines Limited’s EBITDA is 4.38.
2. Incyte Corporation (INCY)
14.3% sales growth and 7.79% return on equity
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally. The company offers JAKAFI (ruxolitinib), for the treatment of adults with intermediate or high-risk myelofibrosis; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include axatilimab, an anti-CSF-1R monoclonal antibody being developed as a therapy for patients with chronic GVHD as well as in additional immune-mediated diseases; and parsaclisib, a PI3Kd inhibitor which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. It also develops retifanlimab, is in Phase III clinical trials for squamous cell carcinoma of the anal canal and non-small cell lung cancer, and Fast Track designation for the treatment of metastatic MSI-H or DNA mismatch repair (dMMR) endometrial cancer; and INCB99280 and INCB99318 currently under Phase I for the treatment solid tumors. It has collaboration out- license agreements with Novartis, Lilly, Innovent, InnoCare, Maruho, and CMS Aesthetics Limited; and in- license agreements with Agenus, Merus, MacroGenics, Syros, MorphoSys, and Syndax. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Earnings Per Share
As for profitability, Incyte Corporation has a trailing twelve months EPS of $1.5.
PE Ratio
Incyte Corporation has a trailing twelve months price to earnings ratio of 41.47. Meaning, the purchaser of the share is investing $41.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.79%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 3.47B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Incyte Corporation’s EBITDA is 246.98.
Moving Average
Incyte Corporation’s worth is below its 50-day moving average of $65.10 and way below its 200-day moving average of $73.47.
3. Mitek Systems (MITK)
14.1% sales growth and 3.69% return on equity
Mitek Systems, Inc. develops, markets, and sells mobile image capture and digital identity verification solutions in the United States, Europe, Latin America, and internationally. The company's solutions are embedded in native mobile apps and browsers to facilitate online user experiences, fraud detection and reduction, and compliant transactions. It offers Mobile Deposit that enables individuals and businesses to remotely deposit checks using their camera-equipped smartphone or tablet; and Mobile Verify, an identity verification solution that is integrated into mobile apps, mobile websites, and desktop applications. The company also provides Mobile Fill, an application to prefill forms with user data by snapping a picture of the driver license or other similar identity documents; Mobile Docs, a mobile document scanning solution; and MiSnap, an image capture technology. In addition, it offers CheckReader that enables financial institutions to automatically extract data from checks; XE, a recurrent neural network engine; and ID_CLOUD, an automated identity verification solution that is integrated into a customers' application to read and validate identity documents. The company sells its solutions primarily to banks, credit unions, lenders, payments processers, card issuers, fintech companies, and others through direct sales teams and channel partners. Mitek Systems, Inc. was incorporated in 1986 and is based in San Diego, California.
Earnings Per Share
As for profitability, Mitek Systems has a trailing twelve months EPS of $0.15.
PE Ratio
Mitek Systems has a trailing twelve months price to earnings ratio of 72.27. Meaning, the purchaser of the share is investing $72.27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.69%.
Volume
Today’s last reported volume for Mitek Systems is 578030 which is 93.25% above its average volume of 299096.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.8%, now sitting on 139.79M for the twelve trailing months.
Moving Average
Mitek Systems’s value is above its 50-day moving average of $9.91 and higher than its 200-day moving average of $9.94.
4. MGM Resorts (MGM)
11.9% sales growth and 9.47% return on equity
MGM Resorts International, through its subsidiaries, owns and operates casino, hotel, and entertainment resorts in the United States and Macau. The company operates through three segments: Las Vegas Strip Resorts, Regional Operations, and MGM China. Its casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. The company's casino operations include slots and table games, as well as online sports betting and iGaming through BetMGM. Its customers include premium gaming customers; leisure and wholesale travel customers; business travelers; and group customers, including conventions, trade associations, and small meetings. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was incorporated in 1986 and is based in Las Vegas, Nevada.
Earnings Per Share
As for profitability, MGM Resorts has a trailing twelve months EPS of $4.59.
PE Ratio
MGM Resorts has a trailing twelve months price to earnings ratio of 9.42. Meaning, the purchaser of the share is investing $9.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.47%.
5. ASML Holding (ASML)
11.7% sales growth and 74.04% return on equity
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Earnings Per Share
As for profitability, ASML Holding has a trailing twelve months EPS of $18.39.
PE Ratio
ASML Holding has a trailing twelve months price to earnings ratio of 37.94. Meaning, the purchaser of the share is investing $37.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 74.04%.
Sales Growth
ASML Holding’s sales growth is 19.4% for the ongoing quarter and 11.7% for the next.
Yearly Top and Bottom Value
ASML Holding’s stock is valued at $697.76 at 11:22 EST, under its 52-week high of $747.13 and way higher than its 52-week low of $363.15.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ASML Holding’s EBITDA is 111.82.
Revenue Growth
Year-on-year quarterly revenue growth grew by 90.9%, now sitting on 24.39B for the twelve trailing months.
Previous days news about ASML Holding(ASML)
- According to Zacks on Wednesday, 5 July, "Despite this underlying strength, macro and geopolitical considerations, including restrictions on trading with China are likely to weigh on stocks like ASML Holding (ASML Quick QuoteASML – Free Report) and Advanced Energy Industries (AEIS Quick QuoteAEIS – Free Report) ."
- Zacks industry outlook highlights ASML holding and advanced energy industries. According to Zacks on Thursday, 6 July, "Chicago, IL - July 6, 2023 - Today, Zacks Equity Research discusses ASML Holding (ASML Quick QuoteASML – Free Report) and Advanced Energy Industries (AEIS Quick QuoteAEIS – Free Report) .", "Despite this underlying strength, macro and geopolitical considerations, including restrictions on trading with China are likely to weigh on stocks like ASML Holding and Advanced Energy Industries."
6. Marriott International (MAR)
9.4% sales growth and 286.4% return on equity
Marriott International, Inc. operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties worldwide. The company operates through U.S. and Canada, and International segments. It operates its properties under the JW Marriott, The Ritz-Carlton, Ritz-Carlton Reserve, W Hotels, The Luxury Collection, St. Regis, EDITION, Bvlgari, Renaissance, Le Méridien, Marriott, Sheraton, Westin, Four Points, Delta Hotels by Marriott, Autograph Collection, Tribute Portfolio, Marriott Hotels, Marriott Executive Apartments, Marriott Vacation Club, Gaylord Hotels, Design Hotels, Courtyard, Residence Inn, Fairfield, SpringHill Suites, TownePlace Suites, Protea Hotels, Aloft Hotels, AC Hotels by Marriott, Element Hotels, and Moxy Hotels brand names. It operates properties under 30 brand names in 138 countries and territories. Marriott International, Inc. was founded in 1927 and is headquartered in Bethesda, Maryland.
Earnings Per Share
As for profitability, Marriott International has a trailing twelve months EPS of $8.57.
PE Ratio
Marriott International has a trailing twelve months price to earnings ratio of 21.81. Meaning, the purchaser of the share is investing $21.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 286.4%.
